Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Biomaterials. 2018 Jun 26;179:29–45. doi: 10.1016/j.biomaterials.2018.06.032

Figure 11.

Figure 11

Representative dynamic histomorphometry images of CG/nHA-PEUR grafts showing areas of xylenol orange (red, 8 weeks) and oxytetracycline (yellow-green, 15 weeks) binding. (A–B) New bone formation near the bone-graft interface in the (A) tibial plateau and (B) femoral condyle defects. (C) Appositional growth of new bone parallel to the surface (yellow arrows) and ingrowth of new bone (white arrows) into CG/nHA-PEUR grafts implanted in a femoral condyle defect. CG denotes ceramic granules and P nHA-PEUR polymer.